tiprankstipranks
Advertisement
Advertisement

RSPH volume surges 19× as Humana draws scrutiny

RSPH volume surges 19× as Humana draws scrutiny

Invesco S&P 500 Equal Weight Health Care ETF (RSPH) has seen unusual trading volume, which is 19× higher than its average daily volume.

Meet Samuel – Your Personal Investing Prophet

Among RSPH’s top holdings, Humana is in focus after Morgan Stanley reiterated a Sell rating and set a price target well below its recent share price, while overall Street sentiment remains at Hold with expectations for downside from current levels. DaVita is also drawing attention following a sizable insider stock sale by its COO shortly after the company delivered a strong Q1 earnings beat and raised multi‑year guidance, with analysts highlighting both improved fundamentals and elevated financial risk. Waters and Cigna saw fresh analyst commentary as well, with Waters receiving a Hold rating and modest upside price target, and Cigna drawing multiple Buy ratings that emphasize its strong cash generation, reduced leverage, and plans for ongoing dividends, buybacks, and selective M&A to support double‑digit earnings growth.

Disclaimer & DisclosureReport an Issue

1